Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID study

P. V. D. van der Voort | A. Koopman | T. Winters | D. Dongelmans | A. Bindels | W. Stilma | L. Pisani | M. Smit | O. Cremer | I. Martín-Loeches | W. Dieperink | N. Juffermans | A. G. Algera | S. D. den Boer | I. Purmer | F. Paulus | R. Determann | M. Onrust | M. Hollmann | J. Roozeman | A. Neto | P. Tuinman | D. Bergmans | N. van Mourik | S. de Bruin | P. van Vliet | W. H. van der Ven | C. Pennartz | J. Haringman | M. Koopmans | A. M. Tsonas | M. Botta | F. Paulus | S. Nijbroek | L. Hol | D. Ivanov | M. Schultz | P. van Velzen | M. Hoogendoorn | O. Baur | M. Schultz | J. Breel | A. Strang | E. Oostdijk | A. V. van Zanten | M. Kuiper | T. Rettig | N. Heijnen | A. Tsonas | L. A. Buiteman-Kruizinga | P. V. D. van der Heiden | M. Sleeswijk | M. D. de Graaff | L. Hagens | R. van der Horst | L. van Welie | E. D. de Klerk | H. de Bruin | A. Vlaar | R. B. V. van Amstel | L. Veldhuis | E. Kho | C. Valk | L. Boers | M. Schuijt | J.P. A.G. C.K. R.B. O.L. P. A.E. D.C.J.J. D.I. F.A. A.J van Akkeren Algera Algoe van Amstel Baur van | J. P. van Akkeren | C. K. Algoe | P. van de Berg | A. E. van den Berg | D. I. van den Bersselaar | F. Bertens | M. D. de Boer | M. Bogerd | L. Bos | C. Bruna | H. Franke | M. Aldridge | S. Hiel | S. T. van der Heide | L. Hoeijmakers | J. Horn | E. Ie | S. Kucukcelebi | D. D. de Lange | J. Pillay | P. Spronk | F. L. Veen | H. H. van der Wier | H. Wesselink | B. van Wijk | W. Y. Wong | D. de Lange | Michiel T.U. Schuijt | M.T.U. Schuijt | L. S. Boers | R. V. van Amstel

[1]  A. Mebazaa,et al.  Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study , 2020, Intensive Care Medicine.

[2]  M. Kuiper,et al.  Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study , 2020, The Lancet Respiratory Medicine.

[3]  M. Shankar-Hari,et al.  COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland , 2020, Intensive Care Medicine.

[4]  A. Deane,et al.  Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU , 2020, Chest.

[5]  J. Horn,et al.  PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands , 2020, Annals of translational medicine.

[6]  Arthur S Slutsky,et al.  Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study , 2020, The Lancet Respiratory Medicine.

[7]  P. Angchaisuksiri,et al.  Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis , 2020, Thrombosis Journal.

[8]  M. Zeitlinger,et al.  Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey , 2020, Critical Care.

[9]  Y. Yeh,et al.  COVID-19 ICU and mechanical ventilation patient characteristics and outcomes—A systematic review and meta-analysis , 2020, medRxiv.

[10]  A. J. Agulló,et al.  Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS , 2020, Intensive Care Medicine.

[11]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[12]  L. Camporota,et al.  COVID-19 pneumonia: different respiratory treatments for different phenotypes? , 2020, Intensive Care Medicine.

[13]  David T. Huang,et al.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. , 2019, The New England journal of medicine.

[14]  Arthur S Slutsky,et al.  Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study , 2019, Anesthesiology.

[15]  J. Laffey,et al.  Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study , 2018, Intensive Care Medicine.

[16]  L. Gattinoni,et al.  Ventilator-related causes of lung injury: the mechanical power , 2016, Intensive Care Medicine.

[17]  L. Blanch,et al.  Assessment of PaO2/FiO2 for stratification of patients with moderate and severe acute respiratory distress syndrome , 2015, BMJ Open.

[18]  S. Jaber,et al.  Prone positioning in severe acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[19]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[20]  R. Chatburn,et al.  Documentation issues for mechanical ventilation in pressure-control modes. , 2010, Respiratory care.

[21]  A. Loundou,et al.  Neuromuscular blockers in early acute respiratory distress syndrome. , 2010, The New England journal of medicine.